MarketBeatThu, 04 Jun 2026 19:03:33 GMTAclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052ACRS+2.40%
Seeking AlphaThu, 14 May 2026 18:30:46 GMTAclaris Therapeutics, Inc. (ACRS) Presents at Bank of America Global Healthcare Conference 2026 TranscriptACRS+2.40%
Zacks Investment ResearchThu, 07 May 2026 13:51:08 GMTAclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue EstimatesACRS+2.40%
Seeking AlphaTue, 28 Apr 2026 18:01:56 GMTAclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates TranscriptACRS+2.40%
